DEVELOPMENT AND VALIDATION OF THE URINARY INCONTINENCE KINESIOPHOBIA SEVERITY SCALE
Development of the Kinesiophobia Severity Scale in Urinary Incontinence: A Validity and Reliability Study
1 other identifier
observational
500
1 country
1
Brief Summary
This study aims to develop and validate a novel Turkish-language self-report instrument, the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI), to assess movement avoidance and fear of movement associated with concerns about urinary leakage in individuals with urinary incontinence. Following scale development, its validity and reliability will be evaluated through psychometric analyses in accordance with the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) recommendations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 21, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 15, 2027
September 25, 2026
September 1, 2026
4 months
September 21, 2026
September 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Content Validity of the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI)
The content validity of the newly developed scale will be evaluated by a multidisciplinary panel of at least 10 experts. Item relevance, clarity, simplicity, and necessity will be assessed using the Content Validity Ratio (CVR), Item-level Content Validity Index (I-CVI), Scale-level Content Validity Index (S-CVI), and modified kappa statistics.
During the initial expert evaluation, before participant recruitment for the main validation study.
Secondary Outcomes (2)
Internal Consistency of the KSS-UI
Baseline (single assessment session; approximately 15-20 minutes).
Item Discrimination and Item Performance of the KSS-UI
Baseline (single assessment session; approximately 15-20 minutes).
Study Arms (1)
Incontinance
This group will consist of individuals with urinary incontinence, including stress, urgency, and mixed urinary incontinence, who are recruited from among relatives of patients attending the Physical Therapy and Rehabilitation Center. Eligible participants who voluntarily agree to participate will complete the newly developed Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI) to assess fear of movement and movement avoidance associated with concerns about urinary leakage. The scale will undergo psychometric evaluation to assess its validity and reliability. No therapeutic intervention will be administered as part of the study.
Eligibility Criteria
The study population will consist of adults aged 18 years or older who report urinary incontinence, including stress, urgency, and mixed urinary incontinence. Participants will be recruited from among relatives of patients attending the Physical Therapy and Rehabilitation Center. Eligible individuals who report urinary leakage at least once per week during the past three months, are able to read and understand Turkish, and voluntarily agree to participate will be included in the study. Individuals with active lower urinary tract infections or conditions that prevent independent completion of the questionnaires will be excluded.
You may qualify if:
- Being 18 years of age or older
- Reporting symptoms of incontinence at least once a week for the past 3 months (ICIQ-SF score ≥ 1)
- Having the ability to read and comprehend Turkish
- Having been informed about the study and provided written informed consent
You may not qualify if:
- Having an active lower urinary tract infection
- Inability to complete the scales independently due to cognitive impairment, advanced dementia, or limited literacy
- Individuals who refuse to participate in the study or do not sign the informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kırşehir Ahi Evran Üniversitesi
Kırşehir, Kırşehir, 40100, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Esra BAYRAMOĞLU DEMİRDÖĞEN
Kırşehir Eğitim ve Araştırma Hastanesi
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
September 21, 2026
First Posted
September 25, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
January 10, 2027
Study Completion (Estimated)
February 15, 2027
Last Updated
September 25, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect participants' privacy and confidentiality, given the sensitive nature of urinary incontinence-related health information. Study findings will be reported in aggregate form.